Arianne Phosphate Inc (DAN)
TSX Venture Exchange · Canada · prices in CAD · close of 16 Oct 2026
Key indicators
| Last close | CAD 0.285 |
|---|---|
| 52-week range | 0.180 – 0.520 |
| Return, 1 month / 3 months | −5.0% / −1.7% |
| Return, 1 year / 3 years | +18.8% / +5.6% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 81.1% |
| Worst drawdown (1 year) | -46.0% |
| Average daily value traded | 0.04M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Arianne Phosphate Inc is a mineral development company based in Canada that is working to develop a phosphate rock project in the Saguenay region of Quebec. The company's focus is on producing phosphate concentrate, a raw material used in agricultural fertilizers and in other industrial applications. Its customers would be fertilizer producers and agricultural supply companies. Arianne Phosphate is engaged mainly in exploration, project development and permitting work rather than in active mining at present.
The shares are listed on the TSX Venture Exchange in Canada under the code DAN, and the price on this page is in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Arianne Phosphate Inc (DAN) trades on the TSX Venture Exchange in Canada. It last closed at CAD 0.285 on 16 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 389 of 1,499 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 18.8% and over the last three months it fell 1.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on TSX Venture Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 62 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -9.7% | ||
| From 52-week high | -43.0% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.7% | ||
| 6-month return | -13.6% | ||
| 12-month return, skipping the last month | 25.0% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 81.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -46.0% | ||
| Liquidity | 79 · Strong | Trades actively. | |
| Average daily value traded | 0.04M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −5.0% |
|---|---|
| 1 month | −5.0% |
| 3 months | −1.7% |
| 6 months | −13.6% |
| 1 year | +18.8% |
| 3 years | +5.6% |
| 5 years | – |
Signals
| 50-day / 200-day average | 0.318 / 0.316 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.019 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on TSX Venture Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.